JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback